High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00447356 |
|
Recruitment Status
:
Withdrawn
(There were no patient enrolled in this study at this site)
First Posted
: March 14, 2007
Last Update Posted
: May 13, 2013
|
Sponsor:
Hackensack University Medical Center
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Hackensack University Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Primary Completion Date : | No date given |
| Study Completion Date : | No date given |